Minerva Neurosciences (NERV)
(Delayed Data from NSDQ)
$3.14 USD
-0.08 (-2.48%)
Updated Jul 19, 2024 04:00 PM ET
3-Hold of 5 3
C Value B Growth B Momentum B VGM
Brokerage Reports
0 items in cart
Minerva Neurosciences, Inc [NERV]
Reports for Purchase
Showing records 41 - 43 ( 43 total )
Company: Minerva Neurosciences, Inc
Industry: Medical - Drugs
Another Win for MIN-202 Differentiates Profile Further
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Minerva Neurosciences, Inc
Industry: Medical - Drugs
Initiating Coverage on Alkermes, Minerva; Assuming Coverage of Trevena
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Minerva Neurosciences, Inc
Industry: Medical - Drugs
A Name for Unmet Needs in Psychiatry; Initiate at Buy With $22 Price Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D